These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8537268)

  • 1. In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae.
    van Rijsoort-Vos JH; Stolz E; Verbrugh HA; Kluytmans JA
    J Antimicrob Chemother; 1995 Jul; 36(1):215-8. PubMed ID: 8537268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae.
    Knapp JS; Neal SW; Parekh MC; Rice RJ
    Antimicrob Agents Chemother; 1995 Apr; 39(4):987-9. PubMed ID: 7786010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
    Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
    Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods.
    Deshpande L; Biedenbach DJ; Jones RN
    Int J Antimicrob Agents; 2001 Nov; 18(5):437-40. PubMed ID: 11711258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.
    Thakur SD; Araya P; Borthagaray G; Galarza P; Hernandez AL; Payares D; Sanabria Cruz OM; Carvallo ME; Corredor AH; Dillon JR
    Sex Transm Dis; 2017 Mar; 44(3):157-160. PubMed ID: 28178114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
    Jiang FX; Lan Q; Le WJ; Su XH
    BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of JNJ-Q2, a novel fluoroquinolone, tested against Neisseria gonorrhoeae, including ciprofloxacin-resistant strains.
    Biedenbach DJ; Turner LL; Jones RN; Farrell DJ
    Diagn Microbiol Infect Dis; 2012 Oct; 74(2):204-6. PubMed ID: 22819604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
    Tanaka M; Tunoe H; Mochida O; Kanayama A; Saika T; Kobayashi I; Naito S
    Diagn Microbiol Infect Dis; 2000 Oct; 38(2):109-13. PubMed ID: 11035242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods.
    Jones RN; Deshpande LM; Erwin ME; Barrett MS; Beach ML
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():67-70. PubMed ID: 10824035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alarming increase in ciprofloxacin- and penicillin-resistant Neisseria gonorrhoeae isolates in New Delhi, India.
    Bala M; Ray K; Kumari S
    Sex Transm Dis; 2003 Jun; 30(6):523-5. PubMed ID: 12782955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of seven quinolone derivatives against Neisseria gonorrhoeae.
    van der Willigen AH; Degener JE; Vogel M; Stolz E; Wagenvoort JH
    Arzneimittelforschung; 1990 Jun; 40(6):684-5. PubMed ID: 2118763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temocillin in vitro activity against recent clinical isolates of Neisseria gonorrhoeae compared with penicillin, ceftriaxone and ciprofloxacin.
    Ghathian K; Calum H; Gyssens IC; Frimodt-Møller N
    J Antimicrob Chemother; 2016 Apr; 71(4):1122-3. PubMed ID: 26747100
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results.
    Jones RN; Barrett MS; Deguchi T
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):193-200. PubMed ID: 9327248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR; Tapsall JW; White PA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany.
    Enders M; Turnwald-Maschler A; Regnath T
    Eur J Clin Microbiol Infect Dis; 2006 May; 25(5):318-22. PubMed ID: 16733613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
    Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.